Sean A. McCarthy - CEO, Director at CytomX Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
CTMX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Sean A. McCarthy - trading volume in the past year for CytomX Therapeutics, Inc.

Holdings reported by Sean A. McCarthy for CytomX Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 988K $4.48M $4.54 Nov 6, 2025 Direct
Common Stock 1.09M $2.93M $2.69 Jun 16, 2025 Direct
Common Stock 93.2K $233K $2.50 Jun 13, 2025 Indirect
Performance Stock Units (PSUs) 285K $0 $1.23 Sep 26, 2025 Direct Common Stock
Stock Option (Right to Buy) 570K Sep 26, 2025 Direct Common Stock
Class A Common Stock 93.2K Nov 6, 2025 Indirect
Performance Stock Units 0 Jun 13, 2025 Direct Common Stock

Transactions reported by Sean A. McCarthy for CytomX Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.